Domain Therapeutics will participate in the SLAS 2023
Domain Therapeutics North America will participate to the SLAS 2023 in San Diego, meet our Scientific Associate Dr Frank Cao, and Business Development Manager Guilhem Dugast during this event.
Do not hesitate to attend Frank’s poster presentation “High-throughput applications for screening GPCR activation using bioSens-All®“ on February 27 at 12 pm PST, at the section 1296-A.
This poster will highlight Domain Therapeutics North America’s expertise for GPCR variant characterization and assay development. Dr Frank Cao will present here the automated screening platform used to profile the complex signaling behaviors induced by GPCR mutants, and will also present a novel in vitro assay detecting adhesion GPCR ADGRE5 activation following mechanical stimulation.